TY  - GEN
AU  - Lahuerta,Juan José
AU  - Mateos,Maria Victoria
AU  - Martínez-López,Joaquin
AU  - Grande,Carlos
AU  - de la Rubia,Javier
AU  - Rosiñol,Laura
AU  - Sureda,Anna
AU  - García-Laraña,José
AU  - Díaz-Mediavilla,Joaquín
AU  - Hernández-García,Miguel T
AU  - Carrera,Dolores
AU  - Besalduch,Joan
AU  - de Arriba,Felipe
AU  - Oriol,Albert
AU  - Escoda,Lourdes
AU  - García-Frade,Javier
AU  - Rivas-González,Concepción
AU  - Alegre,Adrían
AU  - Bladé,Joan
AU  - San Miguel,Jesús F
TI  - Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
SN  - 1592-8721
PY  - 2011///0210
KW  - Aged
KW  - Aged, 80 and over
KW  - Busulfan
KW  - administration & dosage
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Melphalan
KW  - Multiple Myeloma
KW  - mortality
KW  - Myeloablative Agonists
KW  - Retrospective Studies
KW  - Stem Cell Transplantation
KW  - Transplantation Conditioning
KW  - Transplantation, Autologous
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2010.028027
ER  -